8 medicines held by Tillotts Pharma GmbH on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Asacolon 1000 mg Suppository PA2018/005/001 |
Mesalazine | Tillotts Pharma GmbH | Marketed |
| Asacolon 1600 mg modified-release tablets PA2018/004/001 |
Mesalazine | Tillotts Pharma GmbH | Marketed |
| Asacolon 400mg Gastro-Resistant Tablets PA2018/001/001 |
Mesalazine | Tillotts Pharma GmbH | Marketed |
| Asacolon 500 mg Suppositories PA2018/001/003 |
Mesalazine | Tillotts Pharma GmbH | Marketed |
| Asacolon 800mg Gastro-resistant Tablets PA2018/001/002 |
Mesalazine | Tillotts Pharma GmbH | Marketed |
| DIFICLIR 200 mg film-coated tablets EU/1/11/733/001-004 |
Fidaxomicin | Tillotts Pharma GmbH | — |
| DIFICLIR 40 mg/ml granules for oral suspension EU/1/11/733/005 |
Fidaxomicin | Tillotts Pharma GmbH | — |
| Entocort CR 3 mg Gastro-resistant Capsule, Hard PA2018/003/001 |
Budesonide | Tillotts Pharma GmbH | Marketed |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.